Leptin treatment: facts and expectations.

Area of Science:

• Endocrinology
• Metabolism
• Genetics

Background:

• Leptin regulates energy balance, body weight, metabolism, and endocrine function.
• Leptin deficiency causes severe metabolic and endocrine disorders.
• Low leptin levels are observed in lipodystrophy, hypothalamic amenorrhea, and congenital leptin deficiency (CLD).

Purpose of the Study:

• To evaluate the efficacy of leptin replacement therapy in patients with leptin deficiency.
• To explore the potential of leptin therapy in conditions with normal or high leptin levels.
• To highlight the therapeutic potential of understanding leptin's physiological roles.

Main Methods:

• Leptin replacement therapy using metreleptin (recombinant leptin analog).
• Clinical observation of patient phenotypes before and after therapy.
• Evaluation of leptin therapy in various metabolic and endocrine conditions.

Main Results:

• Metreleptin normalized endocrine axes, decreased insulin resistance, and improved lipid profiles and hepatic steatosis in deficient patients.
• Significant weight loss was observed in patients with congenital leptin deficiency (CLD).
• Leptin therapy is being investigated for common obesity, diabetes, and Rabson-Mendenhall syndrome.

Conclusions:

• Leptin replacement therapy is a viable treatment for leptin deficiency syndromes.
• Further research into leptin's functions may unlock new therapies for prevalent diseases.
• Understanding leptin's role is crucial for developing treatments for obesity-associated NAFLD, depression, and dementia.